Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Case report

Wilms tumor, pleuropulmonary blastoma, and DICER1: case report and literature review

Authors: Olivier Abbo, Kalitha Pinnagoda, Laurent Brouchet, Bertrand Leobon, Frédérique Savagner, Isabelle Oliver, Philippe Galinier, Marie-Pierre Castex, Marlène Pasquet

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

Pleuroblastoma (PPB) is a rare pediatric tumor which, in 30% of cases, is associated with cystic nephroma. It has been recently linked to the DICER1 mutation as part of a predisposition syndrome for various tumors. However, if DICER 1 anomalies have been reported in patients with Wilms tumor (WT), to date, no cases of PPB, WT, and DICER1 mutations have been reported in the same patient.

Case presentation

We report the case of a 3-year-old patient, initially managed for metastatic WT. During his clinical course, the diagnosis of a PPB was made after detecting the DICER1 mutation and subsequent management was therefore modified.

Conclusion

This case highlights that in case of simultaneous discovery of a renal tumor and a pulmonary lesion in a child, the DICER 1 mutations should be looked for as these could help adapt management and schedule the surgical procedures.
Literature
1.
go back to reference Messinger YH, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the international Pleuropulmonary Blastoma registry. Cancer. 2015;121(2):276–85.CrossRefPubMed Messinger YH, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the international Pleuropulmonary Blastoma registry. Cancer. 2015;121(2):276–85.CrossRefPubMed
2.
go back to reference Faure A, et al. DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: what the paediatric urologist needs to know. J Pediatr Urol. 2016;12(1):5–10.CrossRefPubMed Faure A, et al. DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: what the paediatric urologist needs to know. J Pediatr Urol. 2016;12(1):5–10.CrossRefPubMed
4.
go back to reference Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: “state-of-the-art” update, 2016. Semin Pediatr Surg. 2016;25(5):250–6.CrossRefPubMed Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: “state-of-the-art” update, 2016. Semin Pediatr Surg. 2016;25(5):250–6.CrossRefPubMed
5.
go back to reference Pritchard-Jones K, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015;386(9999):1156–64.CrossRefPubMed Pritchard-Jones K, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015;386(9999):1156–64.CrossRefPubMed
6.
go back to reference Akpa MM, et al. Wilms tumor suppressor, WT1, cooperates with microRNA-26a and microRNA-101 to suppress translation of the polycomb protein, EZH2, in mesenchymal stem cells. J Biol Chem. 2016;291(8):3785–95.CrossRefPubMed Akpa MM, et al. Wilms tumor suppressor, WT1, cooperates with microRNA-26a and microRNA-101 to suppress translation of the polycomb protein, EZH2, in mesenchymal stem cells. J Biol Chem. 2016;291(8):3785–95.CrossRefPubMed
7.
go back to reference Hill DA, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32(2):282–95.CrossRefPubMed Hill DA, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008;32(2):282–95.CrossRefPubMed
Metadata
Title
Wilms tumor, pleuropulmonary blastoma, and DICER1: case report and literature review
Authors
Olivier Abbo
Kalitha Pinnagoda
Laurent Brouchet
Bertrand Leobon
Frédérique Savagner
Isabelle Oliver
Philippe Galinier
Marie-Pierre Castex
Marlène Pasquet
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1469-4

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue